Aron R. English
Aron R. English's purchase track record
How the stock did after each of Aron R. English's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/18/2025 | CULP | $672K | -28.6% | -17.5% | +17.7% |
| 3/10/2025 | CULP | $545K | -17.6% | -8.9% | +15.7% |
| 12/18/2024 | CULP | $70K | +6.5% | -24.3% | +1.8% |
| 12/9/2024 | CULP | $85K | -6.2% | -22.7% | -0.8% |
| 9/17/2024 | CULP | $1.46M | -8.2% | -8.3% | -0.4% |
| 9/9/2024 | CULP | $79K | -8.1% | -13.7% | +2.6% |
| 7/16/2024 | CULP | $108K | +9.1% | +3.4% | +3.1% |
| 7/8/2024 | CULP | $364K | +25.3% | +19.8% | +7.2% |
| 5/17/2023 | FSTR | $345K | +68.0% | +79.4% | +8.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Stoneridge names Uwe Brandenburg Global VP of Engineering. Stoneridge announced that Uwe Brandenburg has been appointed Global Vice President of Engineering and Innovation. The role is expected to oversee the company's engineering efforts worldwide and drive new product development. The stock is currently trading near its long‑term support level of $7.05 and the RSI sits around the mid‑40s, suggesting modest momentum. The appointment adds to the firm’s leadership team as it continues its growth initiatives.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Lifecore Biomedical to be acquired by Webster Equity Partners. Lifecore Biomedical has announced it will be acquired by Webster Equity Partners in a deal valued at up to $663.7 million. Shareholders may receive up to $9.67 per common equivalent, combining cash and contingent value rights based on performance milestones. This transaction is significant as it represents a full exit for the company, with the potential payout exceeding the current average analyst target of $6.75.
Transaction History
| FSTR | ▼ Sell | Open Market | 38,431 | $1.1M | 4/1/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 1,500 | $42K | 3/31/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 1,887 | $53K | 3/30/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 862 | $24K | 3/27/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 8,968 | $251K | 3/26/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 2,716 | $76K | 3/25/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 25,889 | $730K | 3/24/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 78,414 | $2.2M | 3/23/2026 | View on chart |
| SRI | ▲ Buy | Grant | 23,478 | $0 | 3/16/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 5,124 | $164K | 3/4/2026 | View on chart |
| FSTR | ▼ Sell | Open Market | 13,512 | $362K | 12/12/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 34,025 | $912K | 12/11/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 11,248 | $302K | 12/10/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 4,800 | $129K | 12/9/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 9,765 | $266K | 12/8/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 101 | $3K | 12/1/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 1,307 | $35K | 11/28/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 1,725 | $46K | 11/25/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 27,003 | $725K | 11/24/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 3,412 | $92K | 11/21/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 400 | $11K | 11/17/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 2,247 | $61K | 11/14/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 1,600 | $43K | 11/13/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 3,368 | $91K | 11/12/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 4,813 | $136K | 11/11/2025 | View on chart |
| FSTR | ▼ Sell | Open Market | 2,749 | $76K | 11/11/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 150,419 | $1.1M | 5/28/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 1,139,504 | $7.4M | 5/27/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 96,137 | $649K | 5/23/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 12,334 | $86K | 5/13/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 45,698 | $321K | 5/12/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 700 | $5K | 5/9/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 5,098 | $36K | 5/8/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 15,847 | $111K | 5/7/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 701 | $5K | 5/6/2025 | View on chart |
| LFCR | ▼ Sell | Open Market | 24,543 | $174K | 5/5/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 20,000 | $112K | 3/19/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 104,738 | $560K | 3/18/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 4,220 | $22K | 3/17/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 9,006 | $46K | 3/14/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 9,793 | $50K | 3/13/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 6,077 | $31K | 3/12/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 66,663 | $333K | 3/11/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 13,849 | $64K | 3/10/2025 | View on chart |
| CULP | ▲ Buy | Open Market | 4,564 | $24K | 12/20/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 7,634 | $40K | 12/19/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 1,246 | $7K | 12/18/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 2,300 | $12K | 12/11/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 11,794 | $60K | 12/10/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 2,787 | $14K | 12/9/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 105,242 | $664K | 9/19/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 32,321 | $197K | 9/18/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 102,484 | $600K | 9/17/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 2,453 | $13K | 9/11/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 4,524 | $24K | 9/10/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 7,652 | $41K | 9/9/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 2,671 | $14K | 7/19/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 2,621 | $14K | 7/18/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 5,749 | $30K | 7/17/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 9,703 | $50K | 7/16/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 13,275 | $67K | 7/12/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 22,125 | $111K | 7/10/2024 | View on chart |
| CULP | ▲ Buy | Open Market | 39,248 | $186K | 7/8/2024 | View on chart |
| FSTR | ▲ Buy | Open Market | 9,473 | $106K | 5/18/2023 | View on chart |
| FSTR | ▲ Buy | Open Market | 22,202 | $239K | 5/17/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
L.B. Foster Company Presents at Sidoti Small-Cap Conference
L.B. Foster Company recently presented at the Sidoti Small-Cap Virtual Conference, providing an update on its business operations to investors. The company is also highlighted in a recent market review that identifies small-cap stocks facing challenges. With the stock trading in the middle of its 52-week range, this presentation serves as a standard update for shareholders tracking the firm's progress.
L.B. Foster Company Presents at Sidoti Small-Cap Conference. L.B. Foster Company recently presented at the Sidoti Small-Cap Virtual Conference, providing an update on its business operations to investors. The company is also highlighted in a recent market review that identifies small-cap stocks facing challenges. With the stock trading in the middle of its 52-week range, this presentation serves as a standard update for shareholders tracking the firm's progress.